MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 182959-33-7
MCE 国际站:YM-53601
产品活性:YM-53601 是一种角鲨烯合酶 (squalene synthase) 抑制剂,可降低体内血浆胆固醇和甘油三酯水平。YM-53601 抑制源自人肝癌细胞的角鲨烯合酶,IC50 为 79 nM。可用作降脂剂。YM-53601 还是法呢基二磷酸法呢基转移酶 1 (FDFT1) 酶活性的抑制剂,可抑制 HCV 传播。
研究领域:Metabolic Enzyme/Protease | Anti-infection
作用靶点:Farnesyl Transferase | HCV
In Vitro: YM-53601 inhibits squalene synthase activities in hepatic microsomes from several species of rat, hamster, guinea-pig, rhesus monkey, and human-derived HepG2 cell with IC50s of 90, 170, 46, 45, and 79 nM, respectively.
YM-53601 inhibits conversion of [3H]farnesyl diphosphate to [3H]squalene by hamster liver squalene synthase with the IC50?of 170 nM.
YM-53601 (1 μM) potentiates the susceptibility of H35 cells to thapsigargin, lonidamine, and doxorubicin. YM-53601 (1 μM) reduces the mitochondrial cholesterol levels in both H35 and HepG2 cells.
In Vivo: YM-53601 suppresses cholesterol biosynthesis in rats (ED50, 32?mg/kg).
YM-53601 also reduces plasma non-HDL cholesterol levels in hamsters by approximately 70% at an oral dose of 50 mg/kg/day for 5 days.
YM-53601 potentiates Doxorubicin-mediated hepatocellular carcinoma cells (HCC) growth arrest and cell death in vivo.
相关产品:Bioactive Compound Library Plus | Resiquimod | Honokiol | Ribavirin | Deferiprone | U18666A | AG-1478 | Artemisinin | EIDD-1931 | Tipifarnib | Asunaprevir | Myriocin | Grazoprevir | Simeprevir | NIM811 | Sofosbuvir | Lonafarnib | RO8191 | Vesatolimod | GS-443902 trisodium | L-778123 hydrochloride | Glecaprevir | BLT-1 | Mizoribine | Daclatasvir | Ledipasvir | FTI-277 hydrochloride | Alisporivir | Boceprevir | Cyclo(Phe-Pro) | Azvudine hydrochloride
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds